SEBI warning letter to Balaji Amines over late disclosure of DGFT and FDA orders

Regulatory & Legal View source PDF Explain this filing

BALAMINES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.1%Reaction day

₹2122.10

prior close

₹2050.10

announcement price

In-mkt

timing

Nifty Microcap 250market-1.3%-1.8% vs market

Specialty Chemicals peers, median of 99sector-1.1%-2.0% vs sector

On the reaction day the stock moved 1.8 pts less than Nifty Microcap 250 and 2.0 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.3

10m

-0.5

15m

-0.5

30m

-1.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.1-1.3-1.8-1.1-2.0

Next day

-7.6-1.3-6.3-1.5-6.1

+7.0+0.0+7.0+0.3+6.7

+1.2-0.2+1.4+0.4+0.7

-1.7-3.0+1.3-2.0+0.3

-3.4-2.7-0.7-2.4-1.1

-1.7-1.7-0.0-1.3-0.4

15d

-14.9-8.9-6.1-8.6-6.4

—————

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 99Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

SEBI issued a Warning cum Advisory Letter to Balaji Amines on Sep 29, 2026 for delayed disclosure of two material events: a DGFT order from Aug 13, 2024 and an FDA Maharashtra strict warning letter from Jan 10, 2025. The company states no material financial or operational impact. SEBI has advised stricter compliance and disclosed this letter to exchanges.

Likely market impact

Minor regulatory warning with no financial impact. Risk of stricter enforcement action if compliance does not improve.